-
1
-
-
0344150862
-
-
June 8, Information taken from the Internet
-
FDA report, June 8, 1998 (Information taken from the Internet)
-
(1998)
FDA Report
-
-
-
2
-
-
0344582332
-
Just how safe is sex?
-
Dogar R: Just how safe is sex? Newsweek 1998;June 22:42
-
(1998)
Newsweek
, vol.JUNE 22
, pp. 42
-
-
Dogar, R.1
-
3
-
-
0030154874
-
Sildenafil: An orally active type 5 cycGMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
-
Boolel M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C: Sildenafil: An orally active type 5 cycGMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Im J Impot Res 1996;8:47-52
-
(1996)
Im J Impot Res
, vol.8
, pp. 47-52
-
-
Boolel, M.1
Allen, M.J.2
Ballard, S.A.3
Gepi-Attee, S.4
Muirhead, G.J.5
Naylor, A.M.6
Osterloh, I.H.7
Gingell, C.8
-
4
-
-
0030438222
-
Sildenafil, a novel effective oral therapy for male erectile dysfunction
-
Boolel M, Gepi-Attee S, Gingell JC, Allen MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996;78:257-261
-
(1996)
Br J Urol
, vol.78
, pp. 257-261
-
-
Boolel, M.1
Gepi-Attee, S.2
Gingell, J.C.3
Allen, M.J.4
-
5
-
-
0032516296
-
Oral sildenafil in the treatment of erectile dysfunction
-
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA: Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338;1397-1404
-
(1998)
N Engl J Med
, vol.338
, pp. 1397-1404
-
-
Goldstein, I.1
Lue, T.F.2
Padma-Nathan, H.3
Rosen, R.C.4
Steers, W.D.5
Wicker, P.A.6
-
6
-
-
0031861609
-
Clinical safety of oral sildenafil citrate (Viagra™) in the treatment of erectile dysfunction
-
Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH: Clinical safety of oral sildenafil citrate (Viagra™) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69-74
-
(1998)
Int J Impot Res
, vol.10
, pp. 69-74
-
-
Morales, A.1
Gingell, C.2
Collins, M.3
Wicker, P.A.4
Osterloh, I.H.5
-
7
-
-
0344150860
-
-
Pfizer Viagra®: Script No. 2275, Oct. 14, 1997, p. 24
-
Pfizer Viagra®: Script No. 2275, Oct. 14, 1997, p. 24
-
-
-
-
8
-
-
0025322690
-
Analysis of possible triggers of acute myocardial infarction (the MILIS study)
-
Tofler GH, Stone PH, Maclure M, Edelman E, Davis VG, Robertson T: Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol 1990;66:22-27
-
(1990)
Am J Cardiol
, vol.66
, pp. 22-27
-
-
Tofler, G.H.1
Stone, P.H.2
Maclure, M.3
Edelman, E.4
Davis, V.G.5
Robertson, T.6
-
9
-
-
0027375468
-
Triggering of acute myocardial infarction by heavy physical exertion
-
Mittelman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller J: Triggering of acute myocardial infarction by heavy physical exertion. N Engl J Med 1993;329:1677-1683
-
(1993)
N Engl J Med
, vol.329
, pp. 1677-1683
-
-
Mittelman, M.A.1
Maclure, M.2
Tofler, G.H.3
Sherwood, J.B.4
Goldberg, R.J.5
Muller, J.6
-
10
-
-
0029889718
-
Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of myocardial infarction
-
Muller JE, Mittelman A, Maclure M, Sherwood JB, Tofler GH: Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of myocardial infarction. J Am Med Assoc 1996;275:1405-1409
-
(1996)
J Am Med Assoc
, vol.275
, pp. 1405-1409
-
-
Muller, J.E.1
Mittelman, A.2
Maclure, M.3
Sherwood, J.B.4
Tofler, G.H.5
|